Elise Carlsten

Q: What is Elise Carlsten email address?

Email Elise Carlsten at elise@wolfpackinvestornetwork.com. This email is the most updated Elise Carlsten's email found in 2026.

Q: How to contact Elise Carlsten?

To contact Elise Carlsten send an email to elise@wolfpackinvestornetwork.com. (updated on May 15, 2025)

Due Diligence & Portfolio Company Analyst at Wolfpack Investor Network | Raleigh, North Carolina, United States

About Elise Carlsten

Elise Carlsten currently serves as a Due Diligence & Portfolio Company Analyst at Wolfpack Investor Network, where she plays a pivotal role in identifying and evaluating high-potential startups, particularly those affiliated with NC State. Her deep scientific background, complemented by her ongoing Master of Microbial Biotechnology (2025) and MBA (2026), uniquely positions her to bridge the gap between groundbreaking biotech innovations and strategic investment opportunities. Elise’s expertise in research and development (R&D), combined with her keen attention to detail, enables her to conduct comprehensive financial, market, and competitive analyses that inform sound investment decisions. She is adept at developing in-depth due diligence reports, assessing the viability of startups in health and wellness, and understanding complex scientific concepts such as mammalian cell culture and PFAS-related technologies.

In her role, Elise supports WIN directors, members, and partners by meticulously screening startups, ensuring that only the most promising candidates are considered for funding. Her ability to evaluate the commercial potential of biotech innovations aligns with her passion for the intersection of scientific discovery and business strategy. Beyond due diligence, Elise contributes to community engagement and business development efforts, leveraging her skills in client relations and team leadership to foster strong collaborations within the biotech and investment ecosystems. Her unique blend of scientific expertise and strategic acumen makes her a valuable asset in advancing innovative biotech startups from research labs to market-ready solutions, ultimately driving growth and impact within the industry.

Elise Carlsten Work